• Aug 07, 2024

Walz Discloses No Stocks, Net Worth Trailing Other Candidates

(Bloomberg) -- Minnesota Governor Tim Walz is likely the poorest of the four people on this year’s major-party presidential tickets with a disclosed net worth of under $1 million, following his selection as Democratic nominee Kamala Harris’ running mate.Most Read from BloombergAfrica’s Richest City Needs $12 Billion to Fix InfrastructureNew York City’s Outdoor Dining Sheds Will Start DisappearingThe 5 Coastal States That Face the Most Devastating Flood RiskNew York City Paid $2 Million for Empty

  • Aug 07, 2024

Munis See Biggest Rout in Nearly a Year as Economic Views Swing

(Bloomberg) -- Municipal bonds slid on Wednesday after investors across fixed income markets dialed back a flight to quality bid. Most Read from BloombergAfrica’s Richest City Needs $12 Billion to Fix InfrastructureNew York City’s Outdoor Dining Sheds Will Start DisappearingThe 5 Coastal States That Face the Most Devastating Flood RiskNew York City Paid $2 Million for Empty Hotel Rooms Meant for MigrantsParis Spent €1.4 Billion to Clean Up the Seine. Has It Worked?The biggest rout came in the mi

  • Aug 07, 2024

Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?

Takeda Pharmaceutical Co Ltd (NYSE:TAK) stock is trading higher on Wednesday. Earlier today, the European Commission approved Takeda’s Adzynma (recombinant ADAMTS13) for treating ADAMTS13 deficiency in children and adult patients with congenital thrombotic thrombocytopenic purpura (cTTP). Congenital thrombotic thrombocytopenic purpura, also known as Upshaw-Schulman syndrome, is a rare inherited disorder that affects the blood’s ability to clot properly. This condition leads to the excessive form